SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-051187
Filing Date
2023-10-02
Accepted
2023-10-02 17:17:20
Documents
12
Period of Report
2023-09-29
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 2.06: Material Impairments
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K sqzb-20230929.htm   iXBRL 8-K 63488
  Complete submission text file 0000950170-23-051187.txt   189711

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sqzb-20230929_pre.xml EX-101.PRE 11933
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sqzb-20230929_lab.xml EX-101.LAB 14572
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sqzb-20230929.xsd EX-101.SCH 2468
6 EXTRACTED XBRL INSTANCE DOCUMENT sqzb-20230929_htm.xml XML 4939
Mailing Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472 617-898-8824
SQZ Biotechnologies Co (Filer) CIK: 0001604477 (see all company filings)

IRS No.: 462431115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39662 | Film No.: 231300700
SIC: 2836 Biological Products, (No Diagnostic Substances)